Evidence map›Paper›PMID 29482556›Full record

ReviewMalaria journal2018

Evidence and strategies for malaria prevention and control: a historical analysis.

Gabriel Gachelin, Paul Garner, Eliana Ferroni, Jan Peter Verhave, Annick Opinel

Open access · goldAbstract readHistorical ArticleReview
In one paragraph

Review in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. House modifications for preventing malaria.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. House modifications for preventing malaria.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Ecology of Malaria Mortality: A Spatiotemporal Mapping Approach.American journal of biological anthropology · 2026
    Article
  4. Article
  5. Diverse Biological Activity of Pyrimidine Derivatives: A Review.Current drug discovery technologies · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Safety and Efficacy of Incorporating ActellicTropical medicine and infectious disease · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Malaria: An Overview.Infection and drug resistance · 2023
    Review
  18. Bio-products fromFrontiers in tropical diseases · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Gabriel GachelinLaboratoire SPHere, UMR 7219, Université Paris Diderot. Sorbonne Paris Cité, 4, Rue Elsa Morante, 75013, Paris, France. gabriel.gachelin@gmail.com.
Paul GarnerCentre for Evidence Synthesis in Global Health, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Eliana FerroniEpidemiological Department of the Veneto Region, Passaggio Gaudenzio 1, 35131, Padua, Italy.
Jan Peter VerhaveDept. Med. Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Annick OpinelUMR 1181 Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Institut Pasteur/Inserm/UVSQ, 25, Rue du Dr Roux, 75724, Paris Cedex 15, France.
Institut Pasteur · FRLiverpool School of Tropical Medicine · GBRadboud University Nijmegen · NLRegione del Veneto · ITUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Public health strategies for malaria in endemic countries aim to prevent transmission of the disease and control the vector. This historical analysis considers the strategies for vector control developed during the first four decades of the twentieth century. In 1925, policies and technological advances were debated internationally for the first time after the outbreak of malaria in Europe which followed World War I. This dialogue had implications for policies in Europe, Russia and the Middle East, and influenced the broader international control agenda. The analysis draws on the advances made before 1930, and includes the effects of mosquito-proofing of houses; the use of larvicides (Paris Green) and larvivorous fish (Gambusia); the role of large-scale engineering works; and the emergence of biological approaches to malaria. The importance of strong government and civil servant support was outlined. Despite best efforts of public health authorities, it became clear that it was notoriously difficult to interrupt transmission in areas of moderately high transmission. The importance of combining a variety of measures to achieve control became clear and proved successful in Palestine between 1923 and 1925, and improved education, economic circumstances and sustained political commitment emerge as key factors in the longer term control of malaria. The analysis shows that the principles for many of the present public health strategies for malaria have nearly all been defined before 1930, apart from large scale usage of pesticides, which came later at the end of the Second World War. No single intervention provided an effective single answer to preventing transmission, but certainly approaches taken that are locally relevant and applied in combination, are relevant to today's efforts at elimination.

Indexed as

Communicable Disease ControlDisease Transmission, InfectiousGlobal HealthHistory, 20th CenturyHumansMalariaPublic Health AdministrationGambusiaHistory of malariaHistory of vector controlHouse-proofingInsecticideMarshes sanitationSpecies sanitation

Identifiers

PMID29482556
PMCPMC5828424
OpenAlexW2796132434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.